Showing results (881-890 of 932) with videos related to

Sort By:
Pageof 94
AIDS (London, England)|September 24, 2016
Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in AfricaMyron J Levin, Jane C Lindsey, Susan S Kaplan, et al.
The New England Journal of Medicine|April 29, 2015
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adultsHimal Lal, Anthony L Cunningham, Olivier Godeaux, et al.
Translational Oncology|August 2, 2011
Antitumor efficacy of a thrombospondin 1 mimetic CovX-bodyLingna Li, Tom A Leedom, Janet Do, et al.
Frontiers in Immunology|February 7, 2018
B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus VaccineAdriana Weinberg, Jane Lindsey, Ronald Bosch, et al.
Journal of the American Chemical Society|August 5, 2025
Solid-State Packing Controls Exciton Delocalization and Photophysics in Nonfullerene AcceptorsRobert J E Westbrook, Andrew J Levin, Wei Gao, et al.
The Journal of Infectious Diseases|August 3, 2013
Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccineMyron J Levin, Kenneth E Schmader, John W Gnann, et al.
The New England Journal of Medicine|January 6, 2012
Efficacy results of a trial of a herpes simplex vaccineRobert B Belshe, Peter A Leone, David I Bernstein, et al.
Bone Marrow Transplantation|October 19, 2004
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host diseaseV T Ho, H T Kim, S Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2012
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 yearsKenneth E Schmader, Myron J Levin, John W Gnann, et al.
Archives of Pediatrics & Adolescent Medicine|October 7, 2004
Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocolSusan Schuval, Russell B Van Dyke, Jane C Lindsey, et al.
Pageof 94